Shenzhen Mindray Bio-Medical Electronics has been granted a patent for a sample analysis system and management method. The system includes analysis devices, a scanning component, and a processor to identify sample identifiers for efficient testing. If the identifier cannot be determined, a unique invalid identifier is allocated for specific testing. GlobalData’s report on Shenzhen Mindray Bio-Medical Electronics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Shenzhen Mindray Bio-Medical Electronics, AI-assisted ultrasonography was a key innovation area identified from patents. Shenzhen Mindray Bio-Medical Electronics's grant share as of February 2024 was 62%. Grant share is based on the ratio of number of grants to total number of patents.
Sample analysis system with scanning and image information for identification
A recently granted patent (Publication Number: US11915094B2) discloses a sample analysis system that includes an analysis device, a scanning component, and a processor. The system is designed to test samples by scanning a region containing a sample identifier on a sample holding container before testing the sample. The processor determines the sample identifier based on the scanning information and allocates a unique invalid identifier to the sample if the sample identifier cannot be determined. Additionally, the system includes an image information obtaining component that captures an image of the region containing the sample identifier, providing a backup method for identifying samples in case the scanning information is insufficient.
Furthermore, the sample analysis system features a display with a sample identifier modification interface that allows users to input sample identifiers for invalid samples. The processor generates a sample identifier image based on the captured image and enables users to modify the invalid identifier to the inputted sample identifier. The system also establishes a mapping relationship between the position index and sample identifier of each sample, enabling the processor to determine the sample identifier based on the position index if scanning and image information are insufficient. Additionally, the processor can automatically modify other corresponding invalid identifiers when one invalid identifier is changed, ensuring consistency in sample identification throughout the system. Overall, the patent highlights a comprehensive sample management method that enhances sample identification and testing processes in analysis systems.
To know more about GlobalData’s detailed insights on Shenzhen Mindray Bio-Medical Electronics, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
